Compounds > meglitinide
Page last updated: 2024-08-23

meglitinide and Obesity

meglitinide has been researched along with Obesity in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamdy, O; Mitri, J1
Purnell, JQ; Weyer, C1
Ishibashi, S1
Hermansen, K; Mortensen, LS1

Reviews

4 review(s) available for meglitinide and Obesity

ArticleYear
Diabetes medications and body weight.
    Expert opinion on drug safety, 2009, Volume: 8, Issue:5

    Topics: Abdominal Fat; Benzamides; Body Weight; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Exenatide; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Metformin; Obesity; Peptides; Randomized Controlled Trials as Topic; Sulfonylurea Compounds; Thiazolidinediones; Venoms; Weight Gain; Weight Loss

2009
Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity.
    Treatments in endocrinology, 2003, Volume: 2, Issue:1

    Topics: Amyloid; Benzamides; Biguanides; Body Weight; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Islet Amyloid Polypeptide; Obesity; Peptide Fragments; Protein Precursors; Sulfonylurea Compounds; Thiazolidinediones; Weight Gain

2003
[Management of blood glucose--target of the management and its practice].
    Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64, Issue:11

    Topics: Benzamides; Blood Glucose; Combined Modality Therapy; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diet, Reducing; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Life Style; Obesity; Postprandial Period; Sulfonylurea Compounds; Thiazolidinediones

2006
Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus.
    Drug safety, 2007, Volume: 30, Issue:12

    Topics: Amyloid; Benzamides; Biguanides; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islet Amyloid Polypeptide; Obesity; Sulfonylurea Compounds; Thiazolidinediones; Weight Gain

2007